aspirin has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 15 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morphine is a drug used in chronic pain such as diabetic neuropathy, but the development of tolerance to its antinociceptive effect is an important clinical problem." | 4.31 | Aspirin attenuates morphine antinociceptive tolerance in rats with diabetic neuropathy by inhibiting apoptosis in the dorsal root ganglia. ( Avcı, O; Gunes, H; Gursoy, S; Inan, ZDS; Ozdemir, E; Taskiran, AS, 2023) |
| "In at-risk patients with type 2 diabetes, intensive intervention with multiple drug combinations and behavior modification had sustained beneficial effects with respect to vascular complications and on rates of death from any cause and from cardiovascular causes." | 2.73 | Effect of a multifactorial intervention on mortality in type 2 diabetes. ( Gaede, P; Lund-Andersen, H; Parving, HH; Pedersen, O, 2008) |
| "Pentosidine levels were significantly correlated with severity of retinopathy and neuropathy, but not nephropathy." | 2.68 | Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM. ( Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ozdemir, E | 1 |
| Avcı, O | 1 |
| Inan, ZDS | 1 |
| Taskiran, AS | 1 |
| Gunes, H | 1 |
| Gursoy, S | 1 |
| Cerit, L | 1 |
| Duygu, H | 1 |
| Bhatt, DL | 1 |
| Grosser, T | 1 |
| Dong, JF | 1 |
| Logan, D | 1 |
| Jeske, W | 1 |
| Angiolillo, DJ | 1 |
| Frelinger, AL | 1 |
| Liang, J | 1 |
| Cryer, B | 1 |
| Marathi, U | 1 |
| Micov, A | 1 |
| Tomić, M | 1 |
| Pecikoza, U | 1 |
| Ugrešić, N | 1 |
| Stepanović-Petrović, R | 1 |
| Bhatt, LK | 1 |
| Veeranjaneyulu, A | 1 |
| Brown, AF | 1 |
| Mangione, CM | 1 |
| Saliba, D | 1 |
| Sarkisian, CA | 1 |
| Gaede, P | 1 |
| Lund-Andersen, H | 1 |
| Parving, HH | 1 |
| Pedersen, O | 1 |
| Courteix, C | 1 |
| Bardin, M | 1 |
| Chantelauze, C | 1 |
| Lavarenne, J | 1 |
| Eschalier, A | 1 |
| Homberg, M | 1 |
| Tschöpe, D | 1 |
| Greber, H | 1 |
| Hackländer, T | 1 |
| Schwippert, B | 1 |
| Gries, FA | 1 |
| Mödder, U | 1 |
| Julu, PO | 1 |
| Gow, JW | 1 |
| Jamal, GA | 1 |
| Husstedt, IW | 1 |
| Grotemeyer, KH | 1 |
| Evers, S | 1 |
| Staschewski, F | 1 |
| Wertelewski, R | 1 |
| Contreras, I | 1 |
| Reiser, KM | 1 |
| Martinez, N | 1 |
| Giansante, E | 1 |
| Lopez, T | 1 |
| Suarez, N | 1 |
| Postalian, S | 1 |
| Molina, M | 1 |
| Gonzalez, F | 1 |
| Sanchez, MR | 1 |
| Camejo, M | 1 |
| Blanco, MC | 1 |
| Davis, MD | 1 |
| Fisher, MR | 1 |
| Gangnon, RE | 1 |
| Barton, F | 1 |
| Aiello, LM | 1 |
| Chew, EY | 1 |
| Ferris, FL | 1 |
| Knatterud, GL | 1 |
| Kwaan, HC | 1 |
| Colwell, JA | 1 |
| Cruz, S | 1 |
| Suwanwela, N | 1 |
| Dobbie, JG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study[NCT01480804] | 48 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study[NCT01486290] | 52 participants (Actual) | Interventional | 2007-07-31 | Completed | |||
| The Impact of Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease[NCT03103854] | 500 participants (Anticipated) | Interventional | 2014-01-01 | Recruiting | |||
| Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria[NCT00320008] | 160 participants (Actual) | Interventional | 1992-01-31 | Active, not recruiting | |||
| A Randomised Controlled Trial of a Duodenal Sleeve Bypass Device (EndoBarrier)Compared With Standard Medical Therapy for the Management of Obese Subjects With Type 2 Diabetes[NCT02459561] | 170 participants (Actual) | Interventional | 2015-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for aspirin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Behavior Therapy; Cardiovascular Diseases; | 2008 |
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cy | 1997 |
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Topics: Adolescent; Adult; Aged; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neu | 1998 |
12 other studies available for aspirin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Aspirin attenuates morphine antinociceptive tolerance in rats with diabetic neuropathy by inhibiting apoptosis in the dorsal root ganglia.
Topics: Analgesics; Animals; Apoptosis; Aspirin; bcl-2-Associated X Protein; Caspase 3; Diabetes Mellitus, E | 2023 |
Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
Topics: Aspirin; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Gastroparesis; Humans; Paresis | 2017 |
Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
Topics: Aspirin; Diabetic Neuropathies; Gastroparesis; Humans; Paresis | 2017 |
Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy.
Topics: Acetaminophen; Analgesics; Animals; Aspirin; Diabetic Neuropathies; Dose-Response Relationship, Drug | 2015 |
Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2010 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Aspirin; Clonidine; Diabetes Mellitus, Experi | 1994 |
[Optic neuropathy in type-1 diabetes and acetylsalicylic acid-refractory thrombocyte activation].
Topics: Adult; Aspirin; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropa | 1993 |
Endogenous cyclo-oxygenase substrates mediate the neuroactivity of evening primrose oil in rats.
Topics: Animals; Aspirin; Blood Glucose; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabeti | 1996 |
Progression of distal symmetric polyneuropathy during diabetes mellitus: clinical, neurophysiological, haemorheological changes and self-rating scales of patients.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 1; Diabete | 1997 |
Drugs for pain.
Topics: Acetaminophen; Administration, Oral; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Analgesics | 1998 |
Increased platelet aggregation in diabetes mellitus.
Topics: Adenosine Diphosphate; Aspirin; Blood Chemical Analysis; Blood Proteins; Creatinine; Diabetes Mellit | 1972 |